SelectScience InterviewsDrug Discovery & Development
Robust cell assays for global clinical trials
13 Feb 2025
Charlie Carter
Life Sciences Editor

Thomas (TJ) Beadnell, Scientific Advisor at Eurofins Clinical Trial Solutions, explores key considerations for developing live cell assays to support global clinical trials. He discusses strategies for optimizing assay logistics, ensuring antigen stability, and selecting the right matrix and collection methods to maintain sample integrity. By addressing logistical challenges and best practices in assay development, this video provides valuable insights into building robust, reliable assays that drive successful clinical outcomes. Download the free handout for further detail.